Lexicon Pharmaceuticals
LXRX
#6155
Rank
C$1.49 B
Marketcap
C$3.36
Share price
2.15%
Change (1 day)
100.57%
Change (1 year)

Lexicon Pharmaceuticals (LXRX) - Net assets

Net assets on the balance sheet as of March 2026 : C$0.28 Billion

According to Lexicon Pharmaceuticals 's latest financial reports the company has C$0.28 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Lexicon Pharmaceuticals - Net assets on balance sheet (from 2001 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$C$0.14 B-29.68%
2024-12-31$C$0.20 B69.59%
2023-12-31$C$0.12 B-22.3%
2022-12-31$C$0.15 B9.78%
2021-12-31$C$0.14 B-27.39%
2020-12-31$C$0.19 B30.37%
2019-12-31$C$0.15 B-525.2%
2018-12-31$-C$35.97 Million-141.91%
2017-12-31$C$85.82 M-59.42%
2016-12-31$C$0.21 B-46.66%
2015-12-31$C$0.39 B20.31%
2014-12-31$C$0.32 B81.96%
2013-12-31$C$0.18 B-31.69%
2012-12-31$C$0.26 B-12.39%
2011-12-31$C$0.30 B22.58%
2010-12-31$C$0.24 B43.53%
2009-12-31$C$0.17 B-27.75%
2008-12-31$C$0.23 B-16.71%
2007-12-31$C$0.28 B187.18%
2006-12-31$C$99.54 M-0.35%
2005-12-31$C$99.89 M-31.6%
2004-12-31$C$0.14 B-32.27%
2003-12-31$C$0.21 B-19.65%
2002-12-31$C$0.26 B-22.86%
2001-12-31$C$0.34 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Thermo Fisher Scientific
TMO
C$73.41 B 25,564.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
C$3.77 B 1,219.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
C$44.31 B 15,390.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-C$0.33 Billion-212.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
C$1.40 B 391.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-C$0.44 Billion-251.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-C$0.24 Billion-180.84%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$8.76 B 2,962.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
C$9.67 M-96.62%๐Ÿ‡บ๐Ÿ‡ธ USA